Comment on: "Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis"

International Journal of CancerVolume 153, Issue 1 p. 238-239 LETTER TO THE EDITOR Comment on: “Adverse reactions associated with immune checkpoint inhibitors and bevacizumab: A pharmacovigilance analysis” Yoshihiro Noguchi, Corresponding Author Yoshihiro Noguchi [email protected] orcid.org/0000-0002-9110-9604 Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan Correspondence Yoshihiro Noguchi, Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan. Email: [email protected]Search for more papers by this authorMiao Yan, Miao Yan orcid.org/0000-0002-3582-8305 Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, China Toxicology Counseling Center of Hunan Province (TCCH), Changsha, ChinaSearch for more papers by this author Yoshihiro Noguchi, Corresponding Author Yoshihiro Noguchi [email protected] orcid.org/0000-0002-9110-9604 Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan Correspondence Yoshihiro Noguchi, Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan. Email: [email protected]Search for more papers by this authorMiao Yan, Miao Yan orcid.org/0000-0002-3582-8305 Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China International Research Center for Precision Medicine, Transformative Technology and Software Services, Changsha, China Toxicology Counseling Center of Hunan Province (TCCH), Changsha, ChinaSearch for more papers by this author First published: 09 March 2023 https://doi.org/10.1002/ijc.34498Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume153, Issue11 July 2023Pages 238-239 RelatedInformation